Trial Radar KI | ||
|---|---|---|
Die klinische Studie NCT06843512 für Gewichtsverlust, Nahrungsmittelauswahl ist offene rekrutierung. In der Kartenansicht des Klinische Studien Radar und den KI-Entdeckungstools finden Sie alle Details. Oder stellen Sie hier Ihre Fragen. | ||
Eine Studie entspricht den Filterkriterien
Kartenansicht
Zurück zur Suche
Penn State UniversityIdentifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication 25
Die Details der klinischen Studie sind hauptsächlich auf Englisch verfügbar. Trial Radar KI kann jedoch helfen! Klicken Sie einfach auf 'Studie erklären', um die Informationen zur Studie in der ausgewählten Sprache anzuzeigen und zu besprechen.
Die klinische Studie NCT06843512 ist eine beobachtungsstudie zur Untersuchung von Gewichtsverlust, Nahrungsmittelauswahl und hat den Status offene rekrutierung. Die Studie startete am 15. Juli 2025 und soll 25 Teilnehmer aufnehmen. Durchgeführt von Penn State University ist der Abschluss für 1. Dezember 2026 geplant. Die Daten von ClinicalTrials.gov wurden zuletzt am 10. September 2025 aktualisiert.
Kurzbeschreibung
In recent years, GLP-1 medications have become a widely employed approach by physicians to address weight concerns in patients and lead to weight loss. Little is known, however, about how these medications may alter an individual's attitude towards food, food reactivity, or the specific types and amounts of foods an individual will choose. The purpose of this study is to observe the changes an individual experiences ...Mehr anzeigen
Offizieller Titel
Exploring the Influence of GLP-1 Medication on Food Attitudes and Selection in a Virtual Reality Buffet
Erkrankungen
GewichtsverlustNahrungsmittelauswahlWeitere Studien-IDs
- STUDY00026642
NCT-Nummer
Studienbeginn (tatsächlich)
2025-07-15
Zuletzt aktualisiert
2025-09-10
Studienende (vorauss.)
2026-12
Geplante Rekrutierung
25
Studientyp
Beobachtungsstudie
Status
Offene Rekrutierung
Stichwörter
GLP-1
Weight Loss
Virtual Reality
Food behavior
Weight Loss
Virtual Reality
Food behavior
Studienarme/Interventionen
| Teilnehmergruppe/Studienarm | Intervention/Behandlung |
|---|---|
Nicht zutreffend | GLP-1 Medication Initiation One visit before starting GLP-1 medication and one visit 3 months after. No other changes administered between visits. |
Hauptergebnismessungen
Nebenergebnismessungen
| Ergebnismessung | Beschreibung der Messung | Zeitrahmen |
|---|---|---|
Change from Baseline in Total Weight of Food Selected in the VR Buffet at 3 Months | Baseline and 3 months | |
Change from Baseline in Total Calories of Food Selected in the VR Buffet at 3 Months | Baseline and 3 months | |
Change from Baseline in Energy Density of Food Selected in the VR Buffet at 3 Months | Baseline and 3 months | |
Change from Baseline in Variety of Food Selected in the VR Buffet at 3 Months | Baseline and 3 months |
| Ergebnismessung | Beschreibung der Messung | Zeitrahmen |
|---|---|---|
Change in Baseline Weight Watchers Food Noise Score at 3 Months | Based on participant's answers to the WW Food Noise questionnaire; Scale of 1-5, 1 being strongly disagree and 5 being strongly agree; Higher scores mean more food noise | Baseline and 3 months |
Change in Baseline 9-question External Food Cue Responsiveness Questionnaire Score at 3 Months | Answers are on a 1-4 scale with 1 being "Rarely" and 4 being "A lot"; higher scores suggest more external food cue reactivity | Baseline and 3 months |
Change in Baseline Adult Eating Behavior Score at 3 Months | Answers on a 1-5 scale with 1 being "Strongly disagree" and 5 being "Strongly agree"; 8 subscales, high scores indicate greater expression of subscale measure | Baseline and 3 months |
Change in Baseline Three-Factor Eating Questionnaire Score at 3 Months | Rated on a scale of 1-4 with 1 being "Definitely false" and 4 being "Definitely true"; 3 subscales, higher scales on each means greater expression of that behavior | Baseline and 3 months |
Change in Baseline General Food Craving-Trait Scale Score at 3 Months | Rated on a 0-5 scale with 0 being "Never/not applicable" and 5 being "Always"; higher scores mean more food dependent | Baseline and 3 months |
Change in Baseline Buffet Food Liking Scores at 3 Months | Rated on a 0-100 scale with 0 being "Dislike extremely" and 100 being "Like extremely"; high scores mean greater liking of the food | Baseline and 3 months |
Teilnahme-Assistent
Eignungskriterien
Zugelassene Altersgruppen
Erwachsene, Ältere Erwachsene
Mindestalter
18 Years
Zugelassene Geschlechter
Alle
- Adults (18+) with overweight or obesity (BMI >25 kg/m2)
- Not currently taking an incretin-based medication at baseline
- Recently (within two weeks) prescribed a GLP-1, can be included if they have a obesity-related co-occurring condition (diabetes, hypertension, cardiovascular disease, dyslipidemia)
- Have had no prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
- Fluent in English
- Adults (18+) without overweight or obesity
- <18 years of age at time of testing
- Adults not taking a GLP-1 Medication
- Adults taking a compound GLP-1
- Adults on GLP-1 medication for longer than 2 weeks at baseline
- Have had a prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
- Not fluent in English
Penn State University91 aktive klinische Studien zum ErkundenVerantwortliche Partei
Travis Masterson, Hauptprüfer, Assistant Professor and Director of the Health, Ingestive Behavior, and Technology Lab, Penn State University
Zentrale Studienkontakte
Kontakt: Christina M Blackmon, 425-499-8049, [email protected]
1 Studienstandorte in 1 Ländern
Pennsylvania
Health, Ingestive Behavior, and Technology Laboratory of Pennsylvania State University, State College, Pennsylvania, 16802, United States
Christina M Blackmon, Kontakt, 425-499-8049, [email protected]
Offene Rekrutierung